Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
VNOM
|
Blackstone Holdings Iii L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 210,000 Reduced 0.78% |
$6,188,700
$29.47 p/Share
|
Feb 28
2022 |
TSLA
|
Andrew D Baglino
SVP Powertrain and Energy Eng. |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 15.39% |
$2,855,020
$815.72 p/Share
|
Feb 28
2022 |
TSLA
|
Andrew D Baglino
SVP Powertrain and Energy Eng. |
BUY
Exercise of conversion of derivative security
|
Direct | 3,500 Added 13.33% |
$219,520
$62.72 p/Share
|
Feb 28
2022 |
EVBG
|
Simon Paris |
BUY
Exercise of conversion of derivative security
|
Direct | 1,650 Added 50.0% |
-
|
Feb 28
2022 |
RILY
|
Randall E Paulson
Director |
BUY
Open market or private purchase
|
Direct | 40,000 Added 20.57% |
$2,361,600
$59.04 p/Share
|
Feb 28
2022 |
RILY
|
Thomas J /Adv Kelleher
Co-CEO |
BUY
Open market or private purchase
|
Indirect | 4,300 Added 15.04% |
$252,152
$58.64 p/Share
|
Feb 28
2022 |
RILY
|
Bryant R Riley
Chairman and Co-CEO |
BUY
Open market or private purchase
|
Direct | 49,458 Added 0.91% |
$2,906,647
$58.77 p/Share
|
Feb 28
2022 |
SQ
|
Brian Grassadonia
Ecosystem Lead |
SELL
Open market or private sale
|
Direct | 8,238 Reduced 10.77% |
$987,819
$119.91 p/Share
|
Feb 28
2022 |
COF
|
Timothy P Golden
Controller |
SELL
Open market or private sale
|
Direct | 3,812 Reduced 24.83% |
$567,912
$148.98 p/Share
|
Feb 28
2022 |
CRNX
|
Alan Seth Krasner
Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 14,250 Added 38.71% |
-
|
Feb 28
2022 |
CRNX
|
Stephen F. Betz
Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct | 16,500 Added 10.54% |
-
|
Feb 28
2022 |
CRNX
|
Ajay Madan
Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct | 13,950 Added 6.98% |
-
|
Feb 28
2022 |
CRNX
|
Marc Wilson
CFO |
BUY
Grant, award, or other acquisition
|
Direct | 19,500 Added 19.28% |
-
|
Feb 28
2022 |
CRNX
|
Jeff E. Knight
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,950 Added 50.0% |
-
|
Feb 28
2022 |
CRNX
|
Richard Scott Struthers
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 53,400 Added 48.19% |
-
|
Feb 28
2022 |
ABNB
|
Joseph Gebbia |
SELL
Open market or private sale
|
Direct | 27,588 Reduced 12.0% |
$4,180,685
$151.54 p/Share
|
Feb 28
2022 |
ABNB
|
Joseph Gebbia |
SELL
Open market or private sale
|
Indirect | 470,012 Reduced 1.0% |
$71,230,320
$151.55 p/Share
|
Feb 28
2022 |
ABNB
|
Joseph Gebbia |
BUY
Exercise of conversion of derivative security
|
Direct | 15,525 Added 6.77% |
$623,795
$40.18 p/Share
|
Feb 28
2022 |
ARE
|
Hunter Kass
Co-President and RMD |
SELL
Payment of exercise price or tax liability
|
Direct | 444 Reduced 1.08% |
$84,094
$189.4 p/Share
|
Feb 28
2022 |
ARE
|
Peter M Moglia
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 533 Reduced 0.3% |
$100,950
$189.4 p/Share
|
Feb 28
2022 |
ARE
|
Stephen Richardson
Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 552 Reduced 0.31% |
$104,549
$189.4 p/Share
|
Feb 28
2022 |
MRNA
|
Juan Andres
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 14,462 Added 48.37% |
-
|
Feb 28
2022 |
NEM
|
Stephen P Gottesfeld
EVP and Chief S&EA Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,552 Added 6.78% |
-
|
Feb 28
2022 |
NEM
|
Dean Gehring
EVP, Chief Dev Officer-Peru |
BUY
Grant, award, or other acquisition
|
Direct | 7,552 Added 18.14% |
-
|
Feb 28
2022 |
NEM
|
Jennifer Cmil
EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,552 Added 22.11% |
-
|
Feb 28
2022 |
NEM
|
Nancy Buese
EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 13,091 Added 13.2% |
-
|
Feb 28
2022 |
NEM
|
Robert D Atkinson
EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct | 15,105 Added 15.95% |
-
|
Feb 28
2022 |
NEM
|
Thomas Ronald Palmer
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 44,813 Added 12.39% |
-
|
Feb 28
2022 |
NEM
|
Blake Rhodes
SVP, Strategic Development |
BUY
Grant, award, or other acquisition
|
Direct | 4,229 Added 6.0% |
-
|
Feb 28
2022 |
NEM
|
Nancy Lipson
EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,552 Added 16.89% |
-
|
Feb 28
2022 |
NEM
|
Brian Tabolt
SVP & CAO |
BUY
Grant, award, or other acquisition
|
Direct | 4,191 Added 26.64% |
-
|
Feb 28
2022 |
MCD
|
Catherine M. Engelbert |
BUY
Open market or private purchase
|
Direct | 1,000 Added 32.88% |
$244,180
$244.18 p/Share
|
Feb 28
2022 |
UMPQ
|
Ron L Farnsworth
EVP/CFO |
BUY
Other acquisition or disposition
|
Indirect | 15 Added 0.93% |
-
|
Feb 28
2022 |
UMPQ
|
Ron L Farnsworth
EVP/CFO |
BUY
Grant, award, or other acquisition
|
Direct | 30,444 Added 10.57% |
$649,979
$21.35 p/Share
|
Feb 28
2022 |
UMPQ
|
Neal T Mclaughlin
EVP/Treasurer |
BUY
Other acquisition or disposition
|
Indirect | 11 Added 0.99% |
-
|
Feb 28
2022 |
UMPQ
|
Neal T Mclaughlin
EVP/Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 9,367 Added 6.49% |
$199,985
$21.35 p/Share
|
Feb 28
2022 |
UMPQ
|
Frank Namdar
EVP/Chief Credit Officer |
BUY
Other acquisition or disposition
|
Indirect | 152 Added 2.16% |
-
|
Feb 28
2022 |
UMPQ
|
Frank Namdar
EVP/Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,367 Added 18.96% |
$199,985
$21.35 p/Share
|
Feb 28
2022 |
UMPQ
|
Torran B Nixon
Umpqua Bank President |
BUY
Other acquisition or disposition
|
Indirect | 47 Added 3.18% |
-
|
Feb 28
2022 |
UMPQ
|
Torran B Nixon
Umpqua Bank President |
BUY
Grant, award, or other acquisition
|
Direct | 51,522 Added 18.49% |
$1,099,995
$21.35 p/Share
|
Feb 28
2022 |
UMPQ
|
Cort L O'Haver
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 98,360 Added 16.06% |
$2,099,986
$21.35 p/Share
|
Feb 28
2022 |
UMPQ
|
Andrew H Ognall
EVP/General Counsel/Secretary |
BUY
Other acquisition or disposition
|
Indirect | 92 Added 3.04% |
-
|
Feb 28
2022 |
UMPQ
|
Andrew H Ognall
EVP/General Counsel/Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 16,393 Added 11.65% |
$349,991
$21.35 p/Share
|
Feb 28
2022 |
UMPQ
|
David F Shotwell
EVP/Chief Risk Officer |
BUY
Other acquisition or disposition
|
Indirect | 3 Added 1.19% |
-
|
Feb 28
2022 |
UMPQ
|
David F Shotwell
EVP/Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 17,564 Added 12.8% |
$374,991
$21.35 p/Share
|
Feb 28
2022 |
UMPQ
|
Lisa M White
SVP/Principal Accting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,854 Added 17.26% |
$124,983
$21.35 p/Share
|
Feb 28
2022 |
CTKB
|
Ra Capital Management, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 8,746 Added 0.08% |
$113,436
$12.97 p/Share
|
Feb 28
2022 |
U
|
Marc Whitten
Chief Prod & Tech Officer |
SELL
Open market or private sale
|
Direct | 10,775 Reduced 4.58% |
$1,132,452
$105.1 p/Share
|
Feb 28
2022 |
MSFT
|
Judson Althoff
EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,725 Reduced 1.95% |
$810,170
$297.31 p/Share
|
Feb 28
2022 |
MSFT
|
Christopher C Capossela
EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,852 Reduced 1.78% |
$550,618
$297.31 p/Share
|
Feb 28
2022 |